Le Lézard
Classified in: Health
Subjects: CCA, FVT

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024


Conference Call and Webcast to Follow

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2023 on Wednesday, February 7, 2024, after the market closes.  

Vanda will host a conference call at 4:30 PM ET on Wednesday, February 7, 2024, during which management will discuss the fourth quarter and full year 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 8053170.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, February 7, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, February 14, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8053170.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected] 

SOURCE Vanda Pharmaceuticals Inc.


These press releases may also interest you

at 11:23
The gekotm device is now available through the NHS Supply Chain
UK-based medical device manufacturer Firstkind Ltd, a subsidiary of Sky Medical Technology Ltd, today announced the geko device is available through the UK NHS Supply Chain. The Supply Chain manages the sourcing, delivery and supply of healthcare...

at 11:22
Long Grove will soon offer Premix Vasopressin to help relieve stress on critical care
Long Grove Pharmaceuticals continues to meet the critical care needs of hospital pharmacies with the launch of Premix Vasopressin in its most commonly used concentrations....

at 11:17
RIV Capital Applauds Reports that DEA Plans to Reschedule Cannabis
RIV Capital Inc. ("RIV Capital" or the "Company") , an acquisition and investment firm with a focus on building a leading multi-state platform with one of the strongest portfolios of brands in key strategic U.S. markets, today applauds reports that...

at 11:01
Children's Hope India Honors Three Female Entrepreneurs At Its Annual Spring Luncheon
Nonprofit organization Children's Hope India (CHI) has announced the honorees for this year's Spring Luncheon which will be held on Wednesday, May 8th at Leonard's Palazzo in New York. The luncheon will benefit CHI's "30/30 Education Initiative"...

at 11:00
Mindful Therapy Group Officially Opens in Tempe, Arizona
Mindful Therapy Group (Mindful), a collaborative network of associates and fully licensed, independent mental health clinicians that accepts the majority of regional and national insurers, has officially opened its 5,000-square-foot office in Tempe,...

at 11:00
Green upgrades coming to the Michipicoten First Nation Health Centre
Retrofits and an expansion are coming to the Michipicoten First Nation Health Centre. The federal government is supporting this project with an investment of over $1.5 million from the Green and Inclusive Community Buildings (GICB) program....

More news about Health...


News published on and distributed by: